Drug Trial Radar · NCT01797978
Methylene Blue in Severe Sepsis and Septic Shock
Last checked: Nov 20, 2026Latest source record: Nov 18, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
354
Planned (sponsor's estimate)
Start
Feb 2013
Primary completion
Jan 2016
Study completion Mar 2017
Sponsor
- Lead sponsor
- Seoul National University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 25, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is to see whether the intravenous administration of methylene blue improves the outcome in severe sepsis and septic shock.
Conditions
- Severe Sepsis
- Septic Shock
Interventions
Intravenous methylene blue administrationDrug
Initial history taking and physical examination --\> enrollment --\> 2mg/kg IV bolus followed by 0.5mg/kg/hr slow infusion of methylene blue for 6hrs
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- 28 day mortalityTime frame: within 28 days of diagnosis
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Seoul National University Hospital
Seoul, South Korea · Recruiting
SMG - SNU Boramae Medical Center
Seoul, South Korea · Recruiting
Seoul National University Bundang Hospital
Seongnam-si, Kyeongi-do, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.